Matthew M. Loar serves as Executive at NEUROBIOLOGICAL TECHNOLOGIES INC /CA/, where they oversee executive responsibilities. Since joining the company, Matthew M. Loar has executed 2 insider transactions totaling $18.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 12, 2018 involved purchasing 250,000 shares valued at $0.
Matthew M. Loar currently holds 300,000 shares of NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (NTII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew M. Loar has been a net buyer of NTII stock. They have purchased $18.8K and sold $0 worth of shares.
Matthew M. Loar's most recent insider trade was on Apr 12, 2018, when they purchased 250,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.75 |
| Discretionary |